By bertrand
23/10/2025 Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman PR Cardiawave Appoints Jonathan Freeman as COB – 23 10 2025Download << Press Release
By bertrand
Cardiawave featured by LSI Europe ‘25 as one of the selected innovators presenting in London this September! August 12th 2025 🚀 We are proud to be featured by LSI Europe ‘25 as one of the selected innovators presenting in London this September! Our CEO Carine Schorochoff will showcase non-invasive ultrasound therapy (NIUT) for the treatment of Aortic Stenosis at various stages of the disease. Using non-thermal … Continued
By bertrand
Cardiawave CEO Carine Schorochoff on France Biotech’s 100% HealthTech! August 7th 2025 🫀 Can we treat certain heart conditions without opening the chest? At Cardiawave, we believe the answer is yes. During the 100% HealthTech live broadcast hosted by France Biotech, our CEO Carine Schorochoff was invited to speak on the program Parole d’entrepreneur, moderated by Fabrice Lundy. Carine presented Cardiawave’s mission and … Continued
By bertrand
Cardiawave on Sud Radio July 22nd 2025 📻 Cardiawave was recently featured on Sud Radio, a national French radio station. In this interview, Professor Emmanuel Messas and Dr. Matthieu Pernot, two of the co-founders of Cardiawave, present our non-invasive ultrasound therapy for the treatment of aortic stenosis. They explain the technology, its clinical applications, and the development path of the company. Thanks … Continued
By bertrand
Cardiawave featured by the Parsemus Foundation July 1st 2025 📰 We are pleased to see Valvosoft®, our non-invasive ultrasound therapy for Aortic Valve Stenosis, highlighted in an article by Ben Carlson on the Parsemus Foundation website. The article outlines the potential of non-invasive approaches to address unmet needs in structural heart disease, particularly for patients who may not be eligible for conventional … Continued
By bertrand
Congratulations to our co-founder Mickael Tanter on his election to the French Academy of Sciences! June 26th 2025 🎉 We are proud to congratulate @Mickael Tanter, co-founder of Cardiawave, on his election to the French Academy of Sciences. 🇫🇷 This recognition highlights Mickael’s contributions to biomedical imaging and therapeutic ultrasound. His scientific leadership and pioneering spirit … Continued
By bertrand
Cardiawave au HealthTech Accelerations Summit 2025 ! June 17th 2025 Nous sommes ravis d’annoncer la participation de notre COO, @Maurice Delplanque, au HealthTech Accelerations Summit, qui se tiendra à Paris le 26 juin 2025. Cet événement incontournable, organisé par Biotech Finances, réunit les acteurs clés de l’innovation en santé pour accélérer l’accès des patients aux … Continued
By bertrand
Cardiawave participera à la Journée Start-Up Innovantes du DM 2025! June 6th 2025 🚀Cardiawave participera à la « Journée Start-up Innovantes du DM » organisée par le @SNITEM, le 17 juin à la Cité des Sciences et de l’Industrie à Paris. Notre COO, @Maurice Delplanque, sera présent pour échanger avec l’écosystème dynamique des startups innovantes dans … Continued
By bertrand
Cardiawave announced positive 12-months results at EuroPCR 2025 ! May 23rd 2025 Cardiawave takes a major step forward toward a new era in the non-invasive ultrasound therapy #NIUT of Symptomatic Severe Aortic Stenosis (sSAS) ! 🎉 We are proud to share the positive 100 patients – 12-month results from « Valvosoft®FIM Study » and « Valvosoft® Pivotal Study » presented on May 22 at … Continued
By bertrand
23/05/2025 Cardiawave annonce les résultats positifs à 12 mois de ses études “Valvosoft® FIM Study” et « Valvosoft® Pivotal Study » à l’EuroPCR! DOWNLOAD THE PRESS RELEASE > << Press Release